Von Willebrand Factor--A New Target for TTP Treatment?

N Engl J Med. 2016 Feb 11;374(6):583-5. doi: 10.1056/NEJMe1515876.
No abstract available

Publication types

  • Editorial
  • Comment

MeSH terms

  • Female
  • Fibrinolytic Agents / therapeutic use*
  • Humans
  • Male
  • Purpura, Thrombotic Thrombocytopenic / drug therapy*
  • Single-Domain Antibodies / therapeutic use*
  • von Willebrand Factor / antagonists & inhibitors*

Substances

  • Fibrinolytic Agents
  • Single-Domain Antibodies
  • von Willebrand Factor
  • caplacizumab